MS pathogenesis is complex. Th1/Th17 T lymphocytes become activated in the peripheral immune system and enter the CNS with macrophages to cause white matter inflammatory lesions. Other cells also play a role including B lymphocytes and dendritic cells, to name a few. White matter inflammation leads to demyelination, glial (astrocyte and microglial) activation, and axonal loss. Gray matter also shows pathology with synaptic and neuronal loss. Cortical demyelinating lesions occur which are characterized by a relative paucity of inflammation as compared to white matter lesions, as reviewed. 5 Thus, while MS has been thought to be primarily a white matter disease, important involvement of gray matter has been shown by both neuroimaging and neuropathology.
There are several preclinical models for the study of MS. The relapsing-remitting (RR) model of experimental autoimmune encephalomyelitis (EAE) in SJL mice has been used extensively to study autoimmune responses and has led to many current antiinflammatory treatments for relapsing-remitting multiple sclerosis (RRMS). Other models are well suited for the study of other mechanisms in MS, such as the lysolecithin and cuprizone models to study demyelination and remyelination. Chronic progressive EAE models in C57BL/6 and NOD mice have been used to study neurodegenerative mechanisms in MS, going beyond spinal cord demyelination and axonal loss, to show astrocyte and microglial activation in white and gray matter, as well as neuronal and synaptic loss in gray matter. [6] [7] [8] [9] [10] [11] Magnetic resonance imaging (MRI) has shown T2 lesions in white matter of spinal cord, brainstem, and cerebellum of EAE, 8, [12] [13] [14] with gray matter atrophy in cerebellar and cerebral cortex. 12, 15 There is very little subcortical white matter in mice as compared to humans, so mice are not good models to study periventricular white matter lesions in MS. On the other hand, optic neuritis occurs in EAE with inflammation and demyelination in the optic nerve and thinning of the retinal nerve fiber layer using ocular coherence tomography (OCT). [16] [17] [18] Here, we will study sex differences in autoimmunity and neurodegeneration in MS using the chronic progressive EAE model.
Sex differences in MS
There is increased susceptibility of females compared to males in MS and many autoimmune diseases. 19 Also, immune responses are more robust in healthy females compared to males, including autoantigenspecific responses in MS. [20] [21] [22] [23] In addition, a higher relapse rate was observed in females compared with males who have RRMS throughout the entire duration of disease and at any age. 24 Also, in the first 5 years of disease, RRMS patients with least four relapses per year have a greater female-to-male ratio (3.3:1) than patients who experience no relapses (2.3:1). 24 In contrast, the risk of long-term disability progression is higher in males. 25, 26 A natural history study of untreated MS patients found that male gender was associated with a shorter time to, and a younger age for, conversion to secondary progressive multiple sclerosis (SPMS), 27 while another showed that males have a more severe disease phenotype resulting in faster accumulation of disability. 28 Another showed that being male and of older age at onset predicted more rapid disability progression. 29 Finally, a registry-based study of more than 14,000 patients revealed that male relapse-onset progressive patients accumulated disability faster than female relapse-onset progressive patients. 30 For years, it had been known that the characteristic profile of primary progressive MS was being male, being older, and having spinal cord lesions. 31 A more recent study identified predictors to develop primary progressive MS in a population of subjects with radiologically isolated syndrome (RIS). They found that male sex, older age, and lesions predominantly in spinal cord were the three predictors of evolution from RIS to primary progressive MS. 32 The male propensity to have more disability progression in MS is consistent with males being predisposed to other neurodegenerative diseases such as Parkinson's disease (PD) 33 and amyotrophic lateral sclerosis (ALS). 34 Here, we will address mechanisms underlying the observation that women are more susceptible to MS and have a more relapsing disease course, but men have worse disability progression. This suggests that mechanisms underlying sex differences in susceptibility and relapses differ from mechanisms underlying sex differences in disability progression. 35 A model to ascertain sex chromosome effects on disease Sex differences in MS can be due to sex hormones, sex chromosomes, or both. Roles for sex hormones in sex differences have been studied extensively in preclinical MS models 36 and are being investigated in MS clinical trials. [37] [38] [39] A role for sex chromosomes has been less well studied in EAE and is not mutually exclusive of a role for sex hormones. In preclinical models of disease, gonadectomy to remove effects of sex hormones does not suffice to study sex chromosome effects since differences between gonadectomized female and male mice are confounded by organizational effects of sex hormones from birth to the time of gonadectomy. Instead, the four core genotypes (FCG) have been used to study sex chromosome effects not confounded by a difference in sex hormones. 40 In FCG mice, the Sry gene, which is responsible for testis development, has been deleted from the Y chromosome. Mice which have a deletion of the Sry gene on the Y chromosome are phenotypic females (ovary bearing). They are denoted XY − since they have other Y genes remaining, with only the Sry gene deleted. A comparison between XX and XY − reveals the effect of sex chromosomes on a given outcome measure in a setting of identical gonadal sex, both female. In addition, some mice have the Sry gene added back at an autosomal location resulting in XXSry and XY − Sry mice, again revealing the effect of sex chromosomes in a setting of identical gonadal sex, this time both male. 41 
Sex chromosome effects on autoimmunity
We used the FCG model to determine whether there was a sex chromosome contribution to the increased susceptibility of SJL females compared to males with EAE. 35, 42 We found that immune responses were more encephalitogenic in XX compared to XY − mice during adoptive EAE 43, 44 and that experimental lupus in SJL mice and spontaneous lupus in NZM2328 mice were each more severe in XX compared to XY − . 44, 45 These preclinical observations were consistent with the female predisposition to several autoimmune diseases including MS and systemic lupus erythematosus (SLE). While the findings demonstrated a role for sex chromosomes in sex differences in immune responses, the genes and mechanisms involved remained unknown.
Possible explanations for observed differences between XX versus XY − mice include the following: (a) Y gene presence or absence, (b) differences in X gene dosage, or (c) differences in parental X imprinting of X chromosome genes. Differential imprinting occurs because XY − mice have X genes that are all maternally imprinted, while XX mice have one maternally and one paternally imprinted X chromosome. 46, 47 Because X-inactivation is random, theoretically half of cells express X genes from the maternally imprinted X chromosome and the other half express genes from the paternally imprinted X chromosome. The X chromosome contains a multitude of genes, while the Y chromosome has shortened over evolution, conserving primarily genes related to reproduction. 48 Indeed, several X chromosome genes are known to be involved in immune responses, one of which is Forkhead box p3 (Foxp3). Foxp3 is a transcription factor found in CD4 + CD25 hi T regulatory (T reg ) cells and is considered the "master-regulator" of T reg development and function, with the induction of Foxp3 eliciting downstream immunosuppressive responses. 49, 50 In EAE, Foxp3 + T regs have been shown to regulate myelin protein-specific effector T cells. 51, 52 FOXP3 expression during the induction of T reg function is controlled by epigenetic mechanisms at the transcriptional level that involve Foxp3 DNA methylation. [53] [54] [55] Perhaps most interestingly, it was previously shown that T regs contribute to the relative resistance to EAE in males, as compared to females, 56 but the underlying mechanism for this sex difference remained unknown.
Here, we determined whether differential parental imprinting of X genes could be the source of sex chromosome effects on autoimmunity. Specifically, DNA methylation was quantified in a CG-rich Foxp3 upstream enhancer region using bisulfite sequencing, as described, 57 in CD4+ T cells from lymph node cells of PLP 139-151 immunized SJL mice which carried either the maternal or the paternal imprint. To create mice that had either the maternal or paternal imprint, we used a third genotype XY *x . 58 Mice that are XY *x have one intact X chromosome and, instead of a full Y chromosome, have one pseudoautosomal region with no male-specific region of the Y chromosome. [59] [60] [61] X m Y *x mice with a maternal X chromosome were generated by crossing XX with XY * mice. 58 X p Y *x mice with a paternal X chromosome were generated by crossing X m Y *x females with wild-type XY males. Age 8-12 week X m Y *x mice (maternal X chromosome) and X p Y *x (paternal X chromosome) were then used to determine whether there were maternal versus paternal imprinting differences for Foxp3 in autoantigen-specific T lymphocytes.
We found that CD4 + T cells from X m Y *x mice demonstrated lower percentage methylation of the Foxp3 enhancer region, as compared to those from X p Y *x (Figure 1 ). Methylation causes gene silencing, so this would lead to more FoxP3 expression in males (XY) who express X m genes in all cells as compared to females (XX) who express X m genes in half their cells and X p genes in the other half. Since CD4+CD25+FoxP3+ T cells are immunoregulatory, this would be consistent with less autoimmunity in males (Figure 2 ). These FoxP3 data warrant further DNA methylation studies of other X chromosome genes as well. Also, imprinting effects are not mutually exclusive of X gene dosage Figure 1 . The maternal X imprint, compared to the paternal X imprint, has less Foxp3 methylation. DNA methylation was quantified in a CG-rich Foxp3 upstream enhancer region using bisulfite sequencing, as described 1 in autoantigenspecific T lymphocytes from mice with a maternal X chromosome (X m Y *x ) or a paternal X chromosome (X p Y *x ). The position of each CG site is given on the x-axis using the mouse genome version mm10. effects. However, the majority of X genes undergo X-inactivation, with less than 5% escaping X-inactivation for higher gene dosage in XX compared to XY genotypes. At least for FoxP3, this is not the case since a higher dosage of FoxP3 in XX would be immunoregulatory, opposite from the direction of more autoimmunity in XX. That said, other X chromosome genes could be subject to X-dosage effects. Mapping the methylome and transcriptome of autoantigen-specific CD4+ T lymphocytes as well as other critical immune cells such as macrophages and B lymphocytes in females and males and in mice of the FCG is needed to study sex differences in autoimmunity in MS.
Sex chromosome effects on neurodegeneration
A challenge in MS and EAE involves discerning whether effects on neurodegeneration are merely a consequence of effects on the immune system. Bone marrow chimeras are widely used to study compartmental effects in vivo in EAE. This entails irradiating mice to abolish their immune system followed by reconstitution of their immune system using bone marrow from a donor mouse. Sex chromosome effects on neurodegeneration during EAE can be determined if disease is induced in bone marrow chimeric mice that have an immune system of the same genetic sex, while having a CNS with a different genetic sex (XX or XY).
We used the FCG model to study sex differences due to sex chromosomes, not confounded by differences in sex hormones. We also used bone marrow chimeras to study sex chromosome effects in the CNS, not confounded by differences in the immune system. Specifically, XX versus XY − bone marrow chimeras were reconstituted with a common immune system of one sex chromosome complement. We found that EAE mice with XY − sex chromosome complement in the CNS, compared with XX, demonstrated worse EAE clinical disease severity with more neuropathology in spinal cord (axonal and myelin loss), cerebellum (Purkinje cell and myelin loss), and cerebral cortex (synaptic loss). 7 A candidate gene on the X chromosome, Toll-like receptor 7 (Tlr7), was then examined since it had been shown to mediate neuronal degeneration in cortical neurons. 62 TLR7 protein expression in cortical neurons was higher in mice with XY − , compared with XX, CNS (Figure 3 ). This publication was the first demonstration of a direct effect of sex chromosome complement on neurodegeneration in a neurological disease, 7 and findings were consistent with worse neurodegeneration in XY males as compared to XX females (Figure 4) . Notably, higher TLR7 in neurons of XY mice could not be due to X-dosage effects since Tlr7 is an X gene so would be higher, not lower, in XX if that were the case. That said, without methylation studies, it remains unclear whether the differential expression of TLR7 in neurons during EAE is due to direct effects of maternal versus paternal imprinting of Tlr7. Mapping of the methylome and the transcriptome of neurons as well as other critical CNS cells such as oligodendrocytes or astrocytes in females and males, as well as in mice of the FCG, is needed to study sex differences in disability progression in MS.
Putting sex chromosome effects into perspective with past MS and EAE genetic studies Sex chromosome effects on autoimmunity and neurodegeneration have been shown in the MS preclinical model, and intriguing differences in X chromosome gene methylation and expression have been observed when comparing XX versus XY − mice using the FCG. We suggest that genome-wide methylation and transcriptome studies are needed in critical cell types in the immune and CNSs of females and males with EAE as a model for MS. This focus is new as compared to past genetic studies in MS and EAE. In MS, previous genome-wide association studies (GWAS) confirmed a major role for human leukocyte antigen (HLA) allele inheritance in disease susceptibility and identified numerous other susceptibility loci which contributed, including IL7 receptor and IL2 receptor alpha, to name a few. [63] [64] [65] However, genetic association studies are limited to detection of polymorphisms and do not identify epigenetic effects that can influence gene expression. Also, X and Y chromosome genes were not assessed in GWAS. In EAE, F1 backcrosses confirmed a major role for major histocompatibility complex (MHC) and also identified many other genes which contributed to susceptibility. 66 Consomic studies showed that the Y chromosome of the SJL mouse strain, when bred into mice of another strain's X chromosome and autosomes, conferred increased EAE susceptibility. 67, 68 These studies focused on polymorphic differences in gene sequence. In contrast, mapping the methylome and transcriptome of X chromosome genes and their associated autosomes in females versus males focuses on differences in gene expression of the same sequence.
In MS, genetic factors underlying the increased susceptibility to disease in females have been attributed to Figure 4 . Theoretically, less methylation of the maternal X chromosome would be deleterious for neurodegeneration in XY mice since neurons of XY mice would express more TLR7 due to having the maternal X allele exclusively, as compared to XX who have the maternal X allele expression in only half of their neurons. Tlr7 on Xm, lower methylation, less silencing, higher TLR7 expression, worse neurodegeneration in X m Y males. Tlr7 on Xp, higher methylation, more silencing, less TLR7 expression, less neurodegeneration in X m X p females. Blue crossing over one allele in females indicates random X-inactivation. maternal parent-of-origin disproportionate transmission of the MHC HLA-DRB1*15 (chromosome 6) to female offspring. 69 Other studies have linked maternal parent-of-origin to higher risk of MS in female offspring based on half-sibling studies, avuncular pair studies, extended pedigrees of affected patients, and studies of interracial admixture populations. [70] [71] [72] [73] These clinical observations have prompted the hypothesis of a maternal genetic and female fetal environment interaction during pregnancy that favors the passing of MS susceptibility genes from mother to daughter. Our finding of differences in maternal versus paternal imprinting of X chromosome genes suggests that parental imprinting of X chromosome genes may play a role in maternal parent-of-origin effects.
Compared to disease susceptibility, less is known about genetic factors that lead to disease progression in MS. GWAS in MS found few genetic susceptibility loci in CNS genes. [63] [64] [65] Gene expression array studies have determined that a significantly higher proportion of genes on the X chromosome, as compared to genes on autosomes, are preferentially expressed in the brain compared to other somatic tissues. 74, 75 The accumulation of brain-specific genes located on the X chromosome over evolution puts them in a unique position to influence the CNS response to injury. In EAE or MS, that injury would be an immune attack.
Together, this study of X genes in the FCG mice during EAE warrants further study of X gene methylation and expression in cells of the immune system and the CNS to find new therapeutic targets to recapitulate sex differences in disease susceptibility and progression, respectively.
